186 related articles for article (PubMed ID: 18307925)
1. [Establishment of an animal model of oral mucositis induced by conditioning regimen of haematopoietic stem cell transplantation].
Chen XB; Wang X; Tong XZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Nov; 42(11):672-6. PubMed ID: 18307925
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2.
Vokurka S; Steinerova K; Karas M; Koza V
Bone Marrow Transplant; 2009 Nov; 44(9):601-5. PubMed ID: 19349956
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
4. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
[TBL] [Abstract][Full Text] [Related]
5. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
6. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
7. [The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
Zhu K; Xu Y; Wu D; Xu X; Huang L
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):403-5. PubMed ID: 11877010
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
9. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT--results of a multicentre study.
Vagliano L; Feraut C; Gobetto G; Trunfio A; Errico A; Campani V; Costazza G; Mega A; Matozzo V; Berni M; Alberani F; Banfi MM; Martinelli L; Munaron S; Orlando L; Lubiato L; Leanza S; Guerrato R; Rossetti A; Messina M; Barzetti L; Satta G; Dimonte V
Bone Marrow Transplant; 2011 May; 46(5):727-32. PubMed ID: 20818449
[TBL] [Abstract][Full Text] [Related]
10. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
11. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
[TBL] [Abstract][Full Text] [Related]
12. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.
Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG
Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].
Tong XZ; Xu DR; Zou WY; Li J; Luo SK; Peng AH; Zhang GC; Zheng D
Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559
[TBL] [Abstract][Full Text] [Related]
14. Light-emitting diode therapy in chemotherapy-induced mucositis.
Sacono NT; Costa CA; Bagnato VS; Abreu-e-Lima FC
Lasers Surg Med; 2008 Nov; 40(9):625-33. PubMed ID: 18951429
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
[TBL] [Abstract][Full Text] [Related]
16. Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.
Lima V; Brito GA; Cunha FQ; Rebouças CG; Falcão BA; Augusto RF; Souza ML; Leitão BT; Ribeiro RA
Eur J Oral Sci; 2005 Jun; 113(3):210-7. PubMed ID: 15953245
[TBL] [Abstract][Full Text] [Related]
17. Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation.
Jaguar GC; Prado JD; Nishimoto IN; Pinheiro MC; de Castro DO; da Cruz Perez DE; Alves FA
Oral Dis; 2007 Nov; 13(6):538-43. PubMed ID: 17944669
[TBL] [Abstract][Full Text] [Related]
18. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
19. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
[TBL] [Abstract][Full Text] [Related]
20. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.
McGuire DB; Altomonte V; Peterson DE; Wingard JR; Jones RJ; Grochow LB
Oncol Nurs Forum; 1993; 20(10):1493-502. PubMed ID: 8278277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
